This website is intended for an international audience. To view your own country’s website if available, please select your country from the list provided.
Close
Close
Close
Close
Close
Close

Our diverse portfolio helps us deliver on our commitment to Women's Health

Theramex news

Stay up to date with the latest news from Theramex.

15 November 2021

Theramex Enters Consumer Healthcare Market with Femarelle®, a Non-hormonal Option to Treat Menopause Symptoms

Read more

11 November 2021

Theramex makes a further step towards the consolidation of the fertility footprint by adding Ganirelix Acetate 0.25 mg/ 0.5 mL solution for injection in pre-filled syringe to the existing fertility portfolio

Read more

20 October 2021

Women urged to ask for more from osteoporosis care and treatment, as international survey reveals disease awareness gaps

Read more

14 October 2021

Safety results from large real-world safety study in combined oral contraception published

Read more

29 September 2021

Theramex now has approval for Bijuva® / Bijuve® combined hormone therapy treatment for post-menopausal women*

Read more

27 September 2021

Theramex supports World Contraception Day as it continues to champion women’s rights to effective and reliable birth control

Read more